KRYSTAL BIOTECH INC. - COMMON STOCK

Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer

18 12 2024 08:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels

12 12 2024 08:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa

09 12 2024 16:15:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at Upcoming Investor Conferences

27 11 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at Stifel 2024 Healthcare Conference

12 11 2024 07:00:01 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference

06 11 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

04 11 2024 08:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024

28 10 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference

13 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference

06 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté

28 8 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates

05 8 2024 08:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024

26 7 2024 08:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference

05 6 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference

15 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at BofA Securities 2024 Health Care Conference

08 5 2024 07:00:01 提供 Nasdaq GlobeNewswire

Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates

06 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

02 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024

26 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung

22 4 2024 07:00:00 提供 Nasdaq GlobeNewswire